Indian Glibenclamide Exporters: Complete Supplier Ranking with Market Share — 194 Manufacturers (2026) — TransData Nexus

Q: Who is the largest glibenclamide supplier from India?

MEDOPHARM is the largest glibenclamide exporter from India with a 1.0% market share and export value of $420.3K.

Q: How many glibenclamide suppliers are there in India?

There are 194 active glibenclamide exporters in India, collectively shipping $41.2M worth of glibenclamide across 930 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top glibenclamide suppliers from India?

The top 5 glibenclamide suppliers from India — MEDOPHARM, M. J. BIOPHARM PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, CIPLA LIMITED, CAPLIN POINT LABORATORIES LIMITED — together control 3.6% of total glibenclamide export value from India.

Suresh Sormare

Glibenclamide

India Pharmaceutical Trade Intelligence

$41.2M194 Suppliers100 CountriesHS 30049099

ExportsIndia → SRI LANKA89.8%India → TANZANIA1.6%

ImportsGERMANY → India$20.1K UNITED STATES → India$817

#1 Supplier: MEDOPHARM #1 Buyer: A,BAUR &

Glibenclamide Suppliers from India (2026) — 194 Exporters, $41.2M Market | TransData Nexus | TransData Nexus

Who Exports Glibenclamide from India — 194 Suppliers Behind a $41.2M Market

India's glibenclamide export market is supplied by 194 active exporters who collectively shipped $41.2M across 930 shipments. MEDOPHARM leads with a 1.0% market share, followed by M. J. BIOPHARM PRIVATE LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED. The top 5 suppliers together control 3.6% of total export value, reflecting a moderately competitive market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Glibenclamide Suppliers & Exporters — 194 manufacturers, $41.2M export market, top destinations and formulations — Glibenclamide supplier data — 194 exporters · $41.2M market · 930 shipmentsTransData Nexus · Indian Customs Data

Top Glibenclamide Exporters from India — Ranked by Export Value

MEDOPHARM is the leading glibenclamide exporter from India, holding a 1.0% share of the $41.2M market across 930 shipments from 194 exporters. The top 5 suppliers — MEDOPHARM, M. J. BIOPHARM PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, CIPLA LIMITED, CAPLIN POINT LABORATORIES LIMITED — collectively control 3.6% of total export value, indicating a competitive market. Individual shares are: MEDOPHARM (1.0%), M. J. BIOPHARM PRIVATE LIMITED (0.9%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (0.7%), CIPLA LIMITED (0.6%), CAPLIN POINT LABORATORIES LIMITED (0.4%).

Top Glibenclamide Exporters from India

Ranked by export value · 194 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Glibenclamide Exporters from India — Ranked by Export Value. 194 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1	MEDOPHARM

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Glibenclamide exporters

Certification and compliance status for top Glibenclamide suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Medopharm Private Limited	Not Listed	Yes, January 2025	No	Not verified	WHO-GMP certified in January 2025.
S Kant Healthcare Limited	Not Listed	Yes, February 2025	No	Not verified	WHO-GMP certified in February 2025.
Sun Pharmaceutical Industries Limited	Approved	Yes	Yes	Multiple	FDA-approved with multiple ANDAs; holds WHO-GMP and EU GMP certifications.
Cipla Limited	Approved	Yes	Yes	Multiple	FDA-approved with multiple ANDAs; holds WHO-GMP and EU GMP certifications.
Zydus Lifesciences Limited	Approved	Yes	Yes	Multiple	FDA-approved with multiple ANDAs; holds WHO-GMP and EU GMP certifications; recei
Intas Pharmaceuticals Limited	Approved	Yes	Yes	Multiple	FDA-approved with multiple ANDAs; holds WHO-GMP and EU GMP certifications.

TransData Nexus reviewed the regulatory standing of 6 leading Glibenclamide exporters from India. 4 hold US FDA facility approvals, 6 maintain WHO-GMP certification, and 4 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Glibenclamide sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a central hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts Genome Valley, India's first biotech cluster, and is home to over 800 pharmaceutical companies, including major players like Dr. Reddy’s Laboratories, Aurobindo Pharma, and Divi’s Laboratories. This concentration of industry and advanced R&D infrastructure makes Hyderabad a key player in the pharmaceutical sector.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production and houses a mature pharma ecosystem. The region is home to companies such as Zydus Cadila, Intas Pharmaceuticals, Torrent Pharmaceuticals, and Cadila Pharmaceuticals. The strong support infrastructure, including ports, roads, and utilities, further enhances its appeal as a formulations hub.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt in Maharashtra serves as a critical export gateway for pharmaceuticals. With 929 pharmaceutical units, Maharashtra is a significant contributor to India's pharma industry. The region's proximity to major ports facilitates efficient export operations, making it a strategic location for companies aiming to access international markets.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Glibenclamide exporters from India

January 2024

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires remaining stake in Taro Pharmaceuticals

Sun Pharma entered into a definitive merger agreement to acquire the remaining stake in Taro Pharmaceuticals for $347.73 million. This acquisition consolidates Sun Pharma's dermatology portfolio and enhances its presence in the U.S. market. - IMPACT: This consolidation may streamline operations, potentially affecting Glibenclamide production and export strategies.

Impact: This consolidation may streamline operations, potentially affecting Glibenclamide production and export strategies.

March 2025

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

Sun Pharma announced the acquisition of Checkpoint Therapeutics, an immunotherapy and targeted oncology company, for $355 million. This move aims to strengthen Sun Pharma's oncology pipeline and expand its specialty product offerings. - IMPACT: While primarily focused on oncology, the acquisition could lead to resource reallocation, indirectly influencing Glibenclamide export volumes.

Impact: While primarily focused on oncology, the acquisition could lead to resource reallocation, indirectly influencing Glibenclamide export volumes.

Common Questions — Glibenclamide Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which glibenclamide supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, MEDOPHARM leads with 48 recorded shipments worth $420.3K. M. J. BIOPHARM PRIVATE LIMITED (10 shipments) and SUN PHARMACEUTICAL INDUSTRIES LIMITED (9 shipments) are also established high-volume exporters.

Q How many glibenclamide manufacturers are there in India?

India has 194 active glibenclamide exporters with a combined export market of $41.2M across 930 shipments to 100 countries. The top 5 suppliers hold 3.6% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for glibenclamide from India?

Average FOB unit price: $1.47 per unit, ranging from $0.00 to $51.06. Average shipment value: $44.3K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Glibenclamide

Glibenclamide

Who Exports Glibenclamide from India — 194 Suppliers Behind a $41.2M Market

Top Glibenclamide Exporters from India — Ranked by Export Value

Top Glibenclamide Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Sun Pharmaceutical Industries Limited — Sun Pharma acquires remaining stake in Taro Pharmaceuticals

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

Common Questions — Glibenclamide Suppliers from India

Q Which glibenclamide supplier from India is the most reliable for bulk orders?

Q How many glibenclamide manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for glibenclamide from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Cipla Limited — Cipla acquires Ivia Beaute’s personal care brands

Analysis Methodology